Abundance and state of phosphorylation of the retinoblastoma gene product in human pituitary tumors

International Journal of Cancer

Volumn 67, Issue 1, 1996, Pages 16-19

  Woloschak, M ^a   Yu, A ^a   Xiao, J ^a   Post, K D ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; MUTANT PROTEIN;

ALLELE; ARTICLE; CONTROLLED STUDY; EXON; GENE MUTATION; GENE TARGETING; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; HYPOPHYSIS TUMOR; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; DNA, NEOPLASM; FEMALE; HUMANS; MALE; MOLECULAR SEQUENCE DATA; MUTATION; PHOSPHORYLATION; PITUITARY NEOPLASMS; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RETINOBLASTOMA PROTEIN;

EID: 0030057813     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960703)67:1<16::AID-IJC4>3.0.CO;2-2     Document Type: Article

References (34)

1. ALEXANDER, J.M., BILLER, B.M.K., BIKKAL, H., ZERVAS, N.T. and ARNOLD, A., Clinically non-functioning pituitary tumors are monoclonal in origin. J. clin. Invest., 86, 336-340 (1990).
2. ALVARO, V., TOURAINE, P., VOZARI, R.R., BAI-GRENIER, F., BIRMAN, P. and JOUBERT, D., Protein-kinase-C activity and expression in normal and adenomatous human pituitaries. Int. J. Cancer, 50, 724-730 (1992).
3. BERTHERAT, J., CHANSON, P. and MONTMINY, M., The cyclic adenosine 3′,5′-monophosphate-responsive factor CREB is constitutively activated in human somatotroph adenomas. Mol. Endocrinol., 9, 777-783 (1995).
4. BOOKSTEIN, R.J., SHEW, P., CHEN, P., SCULLY, P. and LEE, W., Suppression of tumorigenicity of human prostate-carcinoma cells by replacing a mutated Rb gene. Science, 247, 712-715 (1990).
5. BYSTROM, C., LARSSON, C., BLOMBERG, C., SANDELIN, K., FALKMER, U., SKOGSEID, B., OBERG, K., WERNER, S. and NORDENSKJOLD, M., Localization of the MEN-1 gene to a small region within chromosome 11q13 by deletion mapping in tumors. Proc. nat. Acad. Sci. (Wash.), 87, 1968-1972 (1990).
6. CHEN, P.-L., SCULLY, P., SHEW, J.-Y., WANG, J.Y.J. and LEE, W-H., Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell, 58, 1193-1198 (1989).
7. CLARKE, A.R., MAANDAG, E.R., VAN ROON, M., VAN DER LUGT, N.M., VAN DER VALK, M., HOOPER, M.L., BERNS, A. and TE RIELE, H., Requirement for a functional Rb-1 gene in murine development. Nature (Lond.), 359, 328-330 (1992).
8. CRYNS, V.L., ALEXANDER, J.M., KLIBANSKI, A. and ARNOLD, A., The retinoblastoma gene in human pituitary tumors. J. clin. Endocrinol. Metab., 77, 644-646 (1993).
9. EZZAT, S., SMYTH, H.S., RAMYAR, L. and ASA, S.L., Heterogeneous in vivo and in vitro expression of basic fibroblast growth factor by human pituitary adenomas. J. clin. Endocrinol. Metab., 80, 878-884 (1995).
10. GONSKY, R., HERMAN, V., MELMED, S. and FAGIN, J., Transforming DNA sequences present in human prolactin-secreting pituitary tumors. Mol. Endocrinol., 5, 1687-1695 (1991).
11. GOPE, R. and GOPE, M.L., Abundance and state of phosphorylation of the retinoblastoma gene product in human colon cancer. Mol. cell. Biochem., 110, 123-133 (1992).
12. HENSEL, H., HSIEH, C.L., GAZDAR, A.F. and JOHNSON, B.E., Altered structure and expression of the human retinoblastoma susceptibility gene in small-cell lung cancer. Cancer Res., 50, 3067-3072 (1990).
13. HERMAN, V., DRAZIN, N.Z., GONSKY, R. and MELMED, S., Molecular screening of pituitary adenomas for gene mutations and rearrangements. J. clin. Endocrinol. Metab., 77, 50-55 (1993).
14. HERMAN, V., FAGIN, J., GONSKY, R., KOVACS, K. and MELMED, S., Clonal origins of pituitary adenomas. J. clin. Endocrinol. Metab., 71, 1427-1433 (1990).
15. HOROWITZ, J.M., PARK, S., BOGENMANN, E., CHENG, J., YANDELL, D.W., KAYE, F.J., MINNA, J.D., DRYJA, T.P. and WEINBERG, R.A., Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a sub-set of human tumor cells. Proc. nat. Acad. Sci. (Wash.), 87, 2775-2779 (1990).
16. HOROWITZ, J.M., YANDELL, D.W., PARK, S-H., CANNING, S., WHYTE, P., BUCHKOVICH, K., HARLOW, E., WEINBERG, R.A. and DRYJA, T.P., Point mutational inactivation of the retinoblastoma antioncogene. Science, 243, 937-940 (1989).
17. JACKS, T., FAZELI, A., SCHMITT, E.M., BRONSON, R.T., GOODELL, M.A. and WEINBERG, R.A., Effects of an Rb mutation in the mouse. Nature (Lond.), 359, 295-300 (1992).
18. KARGA, H.J., ALEXANDER, J.M., HEDLEY-WHYTE, E.T., KLIBANSKI, A. and JAMESON, J.L., ras mutations in human pituitary tumors. J. clin. Endocrinol. Metab., 74, 914-919 (1992).
19. KAYE, F.J., KRATZKE, R.A., GERSTTER, J.L. and HOROWITZ, J.M., A single amino-acid substitution results in a retinoblastoma protein defective in phosphorylation and oncoprotein binding. Genetics, 87, 6922-6926 (1990).
20. KORNBLAU, S.M., XU, H.-J., ZHANG, W., HU, S.-X., BERAN, M., SMITH, T.L., HESTER, J., ESTEY, E., BENEDICT, W.F. and DEISSEROTH, A.B., Levels of retinoblastoma protein expression in newly diagnosed acute myelogenous leukemia. Blood, 84, 256-261 (1994).
21. LEE, E.Y-H.P., CHANG, C.-Y., HU, N., WANG, Y.-C.J., LAI, C.-C., HERRUP, K., LEE, W.-H. and BRADLEY, A., Mice deficient for Rb are non-viable and show defects in neurogenesis and haematopoiesis. Nature (Lond.), 359, 288-295 (1992).
22. MORI, N., YOKOTA, J., AKIYAMA, T. and SEMESHIMA, Y., Variable mutations of the Rb gene in small-cell lung carcinoma. Oncogene, 5, 1713-1717 (1990).
23. PEI, L., MELMED, S., SCHEITHAUER, B., KOVACS, K., BENEDICT, W.F. and PRAGER, D., Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (Rb) locus in aggressive pituitary tumors: evidence for a chromosome-13 tumor-suppressor gene other than Rb1. Cancer Res., 55, 1613-1616 (1995).
24. PELLEGRINI, I., BARLIER, A., GUNZ, G., FIGARELLA-BRANGER, D., ENJALBERT, A., GRISOLI, F. and JAOUET, P., pit-1 gene expression in the human pituitary and pituitary adenomas. J. clin. Endocrinol. Metab., 79, 189-196 (1994).
25. PREUDHOMME, C., VACHEE, A., LEPELLEY, P., VANRUMBEKE, M., ZANDECKI, M., QUESNEL, B., COSSON, A. and FENAUS, P., Inactivation of the retinoblastoma gene appears to be very uncommon in myelodys-plastic syndromes. Brit. J. Haematol., 87, 61-67 (1994).
26. SHIMIZU, T., TOGUCHIDA, J., KATO, M.V., KANEKO, A., ISHIZAKI, K. and SASAKI, M.S., Detection of mutations of the Rb-1 gene in retinoblastoma patients by using exon-by-exon PCR-SSCP analysis. Amer. J. hum. Genet., 54, 793-800 (1994).
27. TORDJMAN, K., STERN, N., OUAKNINE, G., YOSSIPHOV, Y., RAZON, N., NORDENSKJOLD, M. and FRIEDMAN, E., Activating mutations of the gsa gene in non-functioning pituitary tumors. J. clin. Endocrinol. Metab., 77, 765-769 (1993).
28. VALLAR, L., SPADA, A. and GIANNATTASIO, G., Altered gs and adenylate-cyclase activity in human GH-secreting pituitary adenomas. Nature (Lond.), 330, 566-568 (1987).
29. WILLIAMSON, E.A., INCE, P.G., HARRISON, D., KENDALL-TAYLOR, P. and HARRIS, P.E., G-protein mutations in human adrenocorticotrophic hormone-secreting adenomas. Europ. J. clin. Invest., 25, 128-131 (1995).
30. WOLOSCHAK, M., ROBERTS, J.L. and POST, K.D., Loss of heterozygosity at the retinoblastoma locus in human pituitary tumors. Cancer, 74, 693-696 (1994).
31. WOLOSCHAK, M., YU, A. and POST, K.D., Detection of polyomaviral DNA sequences in normal and adenomatous human pituitary tissues, using the polymerase chain reaction. Cancer, 76, 490-496 (1995).
32. YANDELL, D.W., SE, D. and CAMPBELL, T.A., Oncogenic point mutations in the human retinoblastoma gene: their application to genetic counseling. New Engl. J. Med., 321, 1689-1695 (1989).
33. ZHU, J., LEON, S.P., BEGGS, A.M., BUSQUE, L., GILLILAND, D.G. and BLACK, P.M., Human pituitary adenomas show no loss of heterozygosity at the retinoblastoma gene locus. J. clin. Endocrinol. Metab., 78, 922-927 (1994).
34. ZIMERING, M.B., KATSUMATA, N., SATO, Y., BRANDI, M.L., AURBACH, G.D. and MARX, S.J., Increased basic fibroblast growth factor in plasma from multiple endocrine neoplasia type 1: relation to pituitary tumor. J. clin. Endocrinol. Metab., 76, 1182-1187 (1993).